Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Dades bibliogràfiques
Autors principals:	Flossmann, O, Jones, R, Jayne, DR, Luqmani, R
Format:	Journal article
Idioma:	English
Publicat:	2006

Ítems similars

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
per: Mukhtyar, C, et al.
Publicat: (2006)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
per: Mukhtyar, C, et al.
Publicat: (2008)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
per: Saket Jha, et al.
Publicat: (2019-01-01)

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
per: Zhi-Ying Li, et al.
Publicat: (2020-08-01)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
per: Moog P, et al.
Publicat: (2015-11-01)

A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
per: Mahmoud M. Mohamed, et al.
Publicat: (2023-07-01)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
per: Walsh, M, et al.
Publicat: (2011)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
per: Robson, J, et al.
Publicat: (2013)

Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis
per: Morishita, K, et al.
Publicat: (2017)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
per: Guerry, M, et al.
Publicat: (2012)

Serum calprotectin in vasculitis associated with antineutrophil cytoplasmic antibodies
per: E. N. Vorkel, et al.
Publicat: (2024-08-01)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
per: E. N. Vorkel, et al.
Publicat: (2024-12-01)

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis
per: Megan M. Sullivan, et al.
Publicat: (2024-01-01)

Health-related quality of life after Rituximab treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis
per: Iva Parvova, et al.
Publicat: (2024-11-01)

Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab
per: Carmen Martín Varas, et al.
Publicat: (2017-09-01)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
per: De Groot, K, et al.
Publicat: (2005)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
per: Deep Shikha, et al.
Publicat: (2015-01-01)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
per: Mukhtyar, C, et al.
Publicat: (2008)

Rituximab in relapsed/refractory antineutrophil cytoplasmic antibody associated vasculitis: A single-center prospective observational study
per: Ekbote Gayatri, et al.
Publicat: (2019-01-01)

Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis
per: Valérie Bénard, et al.
Publicat: (2021-07-01)

Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
per: Katarzyna Wawrzycka-Adamczyk, et al.
Publicat: (2024-08-01)

Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
per: Sunil Kapur, et al.
Publicat: (2021-01-01)

Recent advances in the management of antineutrophil cytoplasmic antibody-associated vasculitis
per: Durga Prasanna Misra, et al.
Publicat: (2019-01-01)

Profiles of cytokines in patients with antineutrophil cytoplasmic antibody-associated vasculitis
per: Weiwei Hao, et al.
Publicat: (2024-07-01)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
per: Noah Huizenga, et al.
Publicat: (2020-04-01)

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
per: T V Beketova
Publicat: (2018-05-01)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
per: Weiran Li, et al.
Publicat: (2021-03-01)

Isolated Antineutrophil Cytoplasmic Antibody-Associated Coronary Vasculitis and Valvulitis
per: Yoon Kook Kim, MD, et al.
Publicat: (2021-02-01)

A severe, antineutrophil cytoplasmic antibody associated, anterior segment vasculitis.
per: Talks, S, et al.
Publicat: (1994)

Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
per: Jamie R. Felzer, et al.
Publicat: (2022-01-01)

Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies
per: O. N. Egorova, et al.
Publicat: (2024-10-01)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis.
per: Sourabh Chand, et al.
Publicat: (2013-01-01)

Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
per: Ulrich Specks, et al.
Publicat: (2025-01-01)

Antineutrophil cytoplasmic antibody-associated vasculitis in a patient with diffuse scleroderma
per: B N Shiva Prasad, et al.
Publicat: (2021-01-01)

The changing paradigm of glucocorticoid therapy in antineutrophil cytoplasmic antibody-associated vasculitis
per: Kunal Chandwar, et al.
Publicat: (2022-01-01)

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives
per: Zdenka Hruskova, et al.
Publicat: (2020-02-01)

Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China
per: Xiang-Yu Han, et al.
Publicat: (2024-05-01)

Treatment of severe perinuclear antineutrophil cytoplasmic antibody–associated vasculitis with efgartigimod
per: Afsoon Ghafari-Saravi, BS, et al.
Publicat: (2024-05-01)

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis
per: Robson, J, et al.
Publicat: (2017)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
per: de Groot, K, et al.
Publicat: (2009)